Evaluation of inactivated Vibrio fluvialis vaccine in Hyline W36 breeding hens

Document Type : Original Article

Authors

10.35066/J040.2018.627

Abstract

Vibrio fluvialis causes disease and significant economic losses in breeding fish. This bacterium is considered as a human pathogen and several species of marine spawning fish. The egg yolk immunoglobulin technology (IgY) has been used to control many microbial infections. The purpose of the present study was to evaluate the vaccine prepared from V. fluivialis bacteria after injection into laying hens. V. fluvialis was admixed by 0.05% formaldehyde after culture in a liquid medium. Then, the pathogen along with Freund’s adjuvant was injected to the Hyline W36 hens as a vaccine for 7 days. Increase of the weight of the hens was measured until Physical maturity and egg production. Then, an Indirect ELISA was designed to detect IgG Anti V. fluivialis. Injection of the vaccine had no significant effect on weight gain of hens and the number and weight of eggs during the experiment. ELISA test showed that antibody titers in the serum of hyper-immunized hens after injection of the fourth booster reached 1: 12800. According to the results obtained and the results of studies by other researchers, egg yolk antibody (IgY), which is the same as IgG, has been shown to inhibit the pathogenicity in lab and farm animals.

Keywords

References

1- Basti AA, Misaghi A, Salehi TZ, Kamkar A. Bacterial pathogens in fresh, smoked and salted Iranian fish. Food Control. 2006;17(3):183–8.
2- Igbinosa EO, Okoh AI. Vibrio fluvialis: an unusual enteric pathogen of increasing public health concern. Int J Environ Res Public Health. 2010;7(10):3628–43.
3- Tizard IR. An introduction to veterinary immunology. WB Saunders.; 1977.
4- Shin JH, Nam SW, Kim JT, Yoon JB, Bang WG, Roe IH. Identification of immunodominant Helicobacter pylori proteins with reactivity to H. pylori-specific egg-yolk immunoglobulin. J Med Microbiol. 2003;52(3):217–22.
5- Bartz CR, Conklin RH, Tunstall CB, Steele JH. Prevention of murine rotavirus infection with chicken egg yolk immunoglobulins. J Infect Dis. 1980;142(3):439–41.
6- Tini M, Jewell UR, Camenisch G, Chilov D, Gassmann M. Generation and application of chicken egg-yolk antibodies. Comp Biochem Physiol part A Mol Integr Physiol. 2002;131(3):569–74.
7- Schade R, Staak C, Hendriksen C, Erhard M, Hugl H, Koch G, et al. The production of avian (egg yolk) antibodies: IgY. Altern Lab Anim. 1996;24:925–34.
8- Bizhanov G, Vyshniauskis GA. comparison of three methods for extracting IgY from the egg yolk of hens immunized with Sendai virus. Vet Res Commun. 2000;24(2):103–13.
9- Jensenius JC, Andersen I, Hau J, Crone M, Koch C. Eggs: conveniently packaged antibodies. Methods for purification of yolk IgG. J Immunol Methods. Elsevier; 1981;46(1):63–8.
10- Polson A, Von Wechmar MB, Van Regenmortel MHV. Isolation of viral IgY antibodies from yolks of immunized hens. Immunol Commun. 1980;9(5):475–93.
11- Larsson A, Balöw RM, Lindahl TL, Forsberg PO. Chicken antibodies: taking advantage of evolution—a review. Poult Sci. 1993;72(10):1807–12.
12- Gassmann M, Thömmes P, Weiser T, Hübscher U. Efficient production of chicken egg yolk antibodies against a conserved mammalian protein. FASEB J. 1990;4(8):2528–32.
13- Schade R, Hlinak A, Marburger A, Henklein P, Morgenstern R, Blankenstein P, et al. Advantages of using egg yolk antibodies in the life sciences: the results of five studies. Altern Lab Anim. 1997;25(5):555–86.
14- Sunwoo HH, Lee EN, Menninen K, Suresh MR, Sim JS. Growth inhibitory effect of chicken egg yolk antibody (IgY) on Escherichia coli O157: H7. J FOOD Sci. 2002;67(4):1486–94.
15- Di Lonardo A, Marcante ML, Poggiali F, Hamsøikova E, Venuti A. Egg yolk antibodies against the E7 oncogenic protein of human papillomavirus type 16. Arch Virol. 2001;146(1):117–25.
16- Sarker SA, Casswall TH, Juneja LR, Hoq E, Hossain I, Fuchs GJ, et al. Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr. 2001;32(1):19–25.
17- Lemamy G, Roger P, Mani J, Robert M, Rochefort H, Brouillet J. High‐affinity antibodies from hen’s‐egg yolks against human mannose‐6‐phosphate/insulin‐like growth‐factor‐II receptor (M6P/IGFII‐R): Characterization and potential use in clinical cancer studies. Int J cancer. 1999;80(6):896–902.
18- Li X, Jing K, Wang X, Li Y, Zhang M, Li Z, et al. Protective effects of chicken egg yolk antibody (IgY) against experimental Vibrio splendidus infection in the sea cucumber (Apostichopus japonicus). Fish Shellfish Immunol. 2016;48:105–11.
19- Huq MI, Alam AK, Brenner DJ, Morris GK. Isolation of Vibrio-like group, EF-6, from patients with diarrhea. J Clin Microbiol. 1980;11(6):621–4.
20- Zhu X, Zhang Z, Liu Z. Preparation of shrimp Vibrio anguillarum IgY and its effect on protecting from artificial infection. Mar Sci. 2008;2:6.
21- Hirai K, Arimitsu H, Umeda K, Yokota K, Shen L, Ayada K, et al. Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera. Acta Med Okayama. 2010;64(3):163–70.
22- Li CH, Lu XJ, Li DF, Chen J. Passive protective effect of chicken egg yolk immunoglobulins against experimental Vibrio anguillarum infection in ayu (Plecoglossus altivelis). Fish Shellfish Immunol. 2014;37(1):108–14.
23- Punyokun K, Hongprayoon R, Srisapoome P, Sirinarumitr T. The production of anti-Vibrio harveyi egg yolk immunoglobulin and evaluation of its stability and neutralisation efficacy. Food Agric Immunol. 2013;24(3):279–94.
 
 
New Findings in Veterinary Microbiology
Volume 1, Issue 1 - Serial Number 1
Spring & Summer 2018
October 2018
Pages 79-87

Files

History

  • Receive Date: 08 January 2018
  • Revise Date: 30 January 2018
  • Accept Date: 11 March 2018

Share

How to cite

Statistics